296 related articles for article (PubMed ID: 23849305)
1. Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart.
Liu YS; Wang X; Jiang WD; Huang ZW; Wang YM; Hao L; Xing JL; Wang L; Liu XX; Lounsbury P; Zhang M; Lu QH
Clin Nephrol; 2013 Sep; 80(3):168-76. PubMed ID: 23849305
[TBL] [Abstract][Full Text] [Related]
2. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
3. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
[TBL] [Abstract][Full Text] [Related]
4. Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3.
Zivlas C; Triposkiadis F; Psarras S; Giamouzis G; Skoularigis I; Chryssanthopoulos S; Kapelouzou A; Ramcharitar S; Barnes E; Papasteriadis E; Cokkinos D
Ther Adv Cardiovasc Dis; 2017 Nov; 11(11):283-295. PubMed ID: 28830298
[TBL] [Abstract][Full Text] [Related]
5. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
Sakuragi S; Ichikawa K; Yamada K; Tanimoto M; Miki T; Otsuka H; Yamamoto K; Kawamoto K; Katayama Y; Tanakaya M; Ito H
Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation.
Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ
Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542
[TBL] [Abstract][Full Text] [Related]
7. Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection.
Vilar E; Boltiador C; Wong J; Viljoen A; Machado A; Uthayakumar A; Farrington K
PLoS One; 2015; 10(12):e0143813. PubMed ID: 26629900
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
Qing X; Furong W; Yunxia L; Jian Z; Xuping W; Ling G
Cardiovasc Diabetol; 2012 Sep; 11():108. PubMed ID: 22978689
[TBL] [Abstract][Full Text] [Related]
9. β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.
Joosten MM; Pai JK; Bertoia ML; Gansevoort RT; Bakker SJ; Cooke JP; Rimm EB; Mukamal KJ
J Am Heart Assoc; 2014 Jun; 3(4):. PubMed ID: 24980133
[TBL] [Abstract][Full Text] [Related]
10. Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria.
Tramonti G; Cipollini I; Annichiarico C; Lorusso P; Panicucci E; Mariani G; Barsotti G
J Nephrol; 2012; 25(6):976-82. PubMed ID: 22307441
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of serum cystatin C in predicting coronary artery disease.
Koc M; Batur MK; Karaarslan O; Abali G
Cardiol J; 2010; 17(4):374-80. PubMed ID: 20690093
[TBL] [Abstract][Full Text] [Related]
12. Plasma biomarker levels and non-obstructive coronary artery disease determined by coronary computed tomography angiography.
Brolin EB; Agewall S; Cederlund K; Ekenbäck C; Henareh L; Malmqvist K; Rück A; Svensson A; Tornvall P
Clin Physiol Funct Imaging; 2018 Mar; 38(2):246-253. PubMed ID: 28168796
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
[TBL] [Abstract][Full Text] [Related]
14. [Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
He J; Ning HB; Zeng YL; Li W; Li K; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):643-646. PubMed ID: 27788718
[No Abstract] [Full Text] [Related]
15. Cystatin C as a predictive marker of renal dysfunction and mid-term outcomes following off-pump coronary artery bypass grafting.
Lee SH; Youn YN; Choo HC; Lee S; Yoo KJ
Heart; 2015 Oct; 101(19):1562-8. PubMed ID: 26215986
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention.
Angeli F; Verdecchia P; Savonitto S; Arraiz G; Zaninotto M; Broccatelli A; Cosma C; De Servi S; Sabino F; Briguori C; Ambrosio G; Cavallini C;
EuroIntervention; 2015 Nov; 11(7):757-64. PubMed ID: 25136879
[TBL] [Abstract][Full Text] [Related]
17. Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarction--contribution of cystatin C assessment.
Derzhko R; Plaksej R; Przewlocka-Kosmala M; Kosmala W
Coron Artery Dis; 2009 Nov; 20(7):453-61. PubMed ID: 19741512
[TBL] [Abstract][Full Text] [Related]
18. The effect of iloprost on renal dysfunction after renal I/R using cystatin C and beta2-microglobulin monitoring.
Sahsivar MO; Narin C; Kiyici A; Toy H; Ege E; Sarigül A
Shock; 2009 Nov; 32(5):498-502. PubMed ID: 19295492
[TBL] [Abstract][Full Text] [Related]
19. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
Patel D; Ahmad S; Silverman A; Lindsay J
Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
[TBL] [Abstract][Full Text] [Related]
20. High levels of serum β2-microglobulin predict severity of coronary artery disease.
You L; Xie R; Hu H; Gu G; Zheng H; Zhang J; Yang X; He X; Cui W
BMC Cardiovasc Disord; 2017 Mar; 17(1):71. PubMed ID: 28249620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
